(secondQuint)Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone.

 The drug tested in this study is called TAK-448.

 TAK-448 was tested to define a dose and dose frequency which results in a clinically relevant improvement in ST in middle-aged and older men with low ST levels.

 This study looked at ST levels in men who took TAK-448.

 The study enrolled 17 participants.

 Participants were randomly assigned (by chance, like flipping a coin) to one of the following treatment groups-which remained undisclosed to the participants and study doctor during the study (unless there is an urgent medical need): - TAK-448 0.

1 mu g - TAK-448 0.

3 mu g - TAK-448 1.

0 mu g - Placebo (dummy inactive injection) - this was a injection that looks like the study drug but has no active ingredient All participants received subcutaneous injection either once daily on Days 1 through 42, or twice weekly on Days 1 through 39 or once weekly on Days 1 through 36.

 This single-center trial was conducted in the United States.

 The overall time to participate in this study is up to 56 days.

 Participants made daily visits to the clinic for 8 weeks, and were contacted by telephone 14 days after last dose of study drug for a follow-up assessment.

.

 Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone@highlight

The purpose of this study is to evaluate the effects on serum testosterone (ST) after 6 weeks of subcutaneous (SC) administration of different doses and dosing frequencies of TAK-448 to middle-aged and older men with low ST levels.

